EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.

ABSTRACT:

SUBMITTER: Chemlal D 

PROVIDER: S-EPMC10457196 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature